Latest stories on IONS
Ionis outlines $875M-$900M 2026 revenue outlook while targeting TRYNGOLZA $3B+ peak sales
Seeking Alpha63 · neutralproduct/pr
Ionis Pharmaceuticals, Inc. (IONS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Ionis Expands Rare Disease Reach With Pediatric FCS Trial for Olezarsen
TipRanks63 · neutralproduct/pr
Why is Ionis Pharmaceuticals stock climbing today?
Investing.com Markets50 · neutralgeneral
IONIS PHARMACEUTICALS INC (IONS) files 8-K
SEC 8-K50 · neutralgeneral
Ionis Pharmaceuticals GAAP EPS of -$0.69 beats by $0.38, revenue of $268M beats by $77.91M
Seeking Alpha68 · bullishearnings
Ionis announces Dr. Frank Bennett, chief scientific officer, to retire | IONS Stock News
StockTitan47 · neutralgeneral
Ionis reports second quarter 2026 financial results and highlights progress on key programs | IONS Stock News
StockTitan50 · neutralearnings
Ionis Pharmaceuticals Q2 2026 Earnings Preview
Seeking Alpha56 · neutralearnings
Ionis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% - HBSS
PR Newswire22 · bearishearnings
Canaccord reiterates Ionis stock rating on Tryngolza advantage
Investing.com Analyst Ratings56 · neutralanalyst
H.C. Wainwright reiterates Ionis Pharmaceuticals stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Guggenheim cuts Ionis stock price target on Tryngolza sales outlook
Investing.com Analyst Ratings38 · neutralanalyst
Cathie Wood Just Bet Big on This Biotech Stock
Yahoo Top56 · neutralanalyst
Cathie Wood Just Bet Big on This Biotech Stock
The Motley Fool58 · neutralanalyst
Ionis Pharmaceuticals: The Heartbreak Is Priced In
Seeking Alpha56 · neutralanalyst
Biogen drops after additional mid-stage trial data for Ionis-partnered Alzheimer’s drug
Seeking Alpha34 · bearishproduct/pr
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
MarketBeat34 · bearishproduct/pr
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome | IONS Stock News
StockTitan63 · neutralproduct/pr
Panic grips Ionis Pharmaceuticals investors amid bad news spree
Yahoo Top28 · bearishproduct/pr
Panic grips Ionis Pharmaceuticals investors amid bad news spree
The Street22 · bearishgeneral
Ionis extends losses as Roche scraps two partnered studies
Seeking Alpha28 · bearishgeneral
Ionis Pharmaceuticals Reaffirms 2026 Financial Guidance Outlook
TipRanks56 · neutralgeneral